Mitos y creencias sobre la insulinoterapia en pacientes con diabetes mellitus y sus familiares de un hospital del norte del Perú, 2020

Jhoana Lorena Vera Ubillús; Blanca Katiuska Loayza Enríquez; Rosa Elizabeth Guarníz Lozano; Franco Ernesto León Jiménez

doi:10.17843/rpmesp.2023.401.12210

Authors

Jhoana Lorena Vera Ubillús Centro de Salud de Quirichima, Lambayeque, Perú. https://orcid.org/0000-0002-5929-9284
Blanca Katiuska Loayza Enríquez Universidad San Martín de Porres, Filial Chiclayo, Chiclayo, Perú
Rosa Elizabeth Guarníz Lozano Universidad Católica Santo Toribio de Mogrovejo, Lambayeque, Perú.
Franco Ernesto León Jiménez Vicerrectorado de Investigación Universidad Privada Norbert Wiener, Lima, Perú. https://orcid.org/0000-0002-9418-3236

DOI:

https://doi.org/10.17843/rpmesp.2023.401.12210

Abstract

Objective. To analyze and explore the myths and beliefs about insulin therapy in patients with diabetes mellitus and their family caregivers from a general hospital in northern Peru in 2020. Materials and methods. This qualitative study used a thematic analysis model, following the interpretative paradigm. Sociodemographic and clinical data were obtained from medical records. Patients with diabetes that used some type of insulin for at least three months prior to the study were interviewed, as well as their family caregivers. Patients participated in a focus group and in-depth interviews; family caregivers participated only in in-depth interviews. Results. Twelve patients with diabetes (11 with type 2 diabetes mellitus) were included; six in the focus group and six in the in-depth interviews. Seven family caregivers were included. After analysis, we obtained four categories: 1) beliefs related to starting insulin treatment: treatment of choice after failure of other drugs, cures diabetes, regulates sugar, fear of injectables; 2) beliefs related to maintaining treatment: decompensation for not using insulin, insulin is necessary to live; 3) beliefs related to alternative therapies and cost: use of alternative therapies, high cost of insulin; and 4) myths related to the use of insulin: generates dependence, dependence for insulin administration, negative effects of insulin. Conclusions. The beliefs and myths of patients treated with insulin arise from the beginning of treatment, are maintained throughout the course of treatment, and are often reinforced by the worldview of family members.

Downloads

Download data is not yet available.

Author Biographies

Jhoana Lorena Vera Ubillús, Centro de Salud de Quirichima, Lambayeque, Perú.

Bachiller en medicina
Franco Ernesto León Jiménez, Vicerrectorado de Investigación Universidad Privada Norbert Wiener, Lima, Perú.

Medico Internista Hospital Santa Rosa Piura, Investigador Universidad privada Norbert Wiener

References

International Diabetes Federation. IDF Diabetes Atlas 2021. 10 TH Edition [Internet]. IDF; 2021 [citado el 21 de enero de 2023]. Disponible en: https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf.

Jiménez-Corona A, Aguilar-Salinas CA, Rojas-Martínez R, Hernández-Ávila M. Diabetes mellitus tipo 2 y frecuencia de acciones para su

prevención y control. Salud pública Méx. 2013;55(2):S137-S143.

Pinto Valdivia M, Guevara Linares X, Huaylinos Párraga Y, Chia Gonzales S, Manrique Hurtado H. Características clínicas y epidemiológicas de los pacientes adultos con diabetes tipo 2 tratados con insulina en un hospital general de Lima. Rev Soc Peru Med Interna. 2019;30(1):6-10.doi: 10.36393/spmi.v30i1.81.

ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S140-S157. doi: 10.2337/dc23-S009.

Davies MJ, Gagliardino JJ, Gray LJ, Khunti K, Mohan V, Hughes R. Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review. Diabet Med. 2013;30(5):512-24. doi: 10.1111/dme.12128.

Flores A. Factores asociados a la no adherencia a insulinoterapia en pacientes con diabetes mellitus 2 de un hospital de Lambayeque 2019-2020 [tesis]. Chiclayo: Universidad Católica Santo Toribio de Mogrovejo; 2022. Disponible en: https://tesis.usat.edu.pe/handle/20.500.12423/4629

Fu AZ, Qiu Y, Radican L. Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes. Curr Med Res Opin. 2009;25(6):1413-20. doi: 10.1185/03007990902905724.

Hermanns N, Ehrmann D, Schall S, Maier B, Haak T, Kulzer B. The effect of an education programme (MEDIAS 2 BSC) of non-intensive insulin treatment regimens for people with Type 2 diabetes: a randomized, multi-centre trial. Diabet Med. 2017;34(8):1084-1091. doi: 10.1111/dme.13346.

Yorke E, Atiase Y. Impact of structured education on glucose control and hypoglycaemia in Type-2 diabetes: a systematic review of randomized controlled trials. Ghana Med J. 2018;52(1):41. doi: 10.4314/gmj. v52i1.8.

Iquize RCC, Theodoro FCET, Carvalho KA, Oliveira M de A, Barros J de F, Silva AR da. Educational practices in diabetic patient and perspective of health professional: a systematic review. J Bras Nefrol. 2017;39(2). doi: 10.1590/1677-5449.210011.

Brod M, Kongsø JH, Lessard S, Christensen TL. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res. 2009;18(1):23-32. doi: 10.1007/s11136-008-9419-1.

Millian A. Myths and Misconceptions about Insulin Therapy among Latinos/ Hispanics with Diabetes: A Fresh Look at an Old Problem. J Diabetes Metab. 2015;06(01):1–5.

Baghikar S, Benitez A, Fernandez Piñeros P, Gao Y, Baig AA. Factors Impacting Adherence to Diabetes Medication Among Urban, Low Income Mexican-Americans with Diabetes. J Immigr Minor Heal. 2019;21(1):1–8. doi: 10.1007/s10903-019-00867-9.

Brod M, Alolga SL, Meneghini L. Barriers to Initiating Insulin in Type 2 Diabetes Patients: Development of a New Patient Education Tool to Address Myths, Misconceptions and Clinical Realities. Patient. 2014;7(4):437–50. doi: 10.1007/s40271-014-0068-x.

Ng CJ, Lai PSM, Lee YK, Azmi SA, Teo CH. Barriers and facilitators to starting insulin in patients with type 2 diabetes: A systematic review. Int J Clin Pract. 2015;69(10):1050–70. doi: 10.1111/ijcp.12691.

Pinzón-Rocha ML, Aponte-Garzón LH, Hernández-Páez RF. Experiencia de los cuidadores informales en el manejo de la diabetes mellitus tipo II. Orinoquia. 2012;17(2):241–51. doi: 10.22579/20112629.22.

Amparo D, Rico P. Características sociodemográficas asociadas a la sobrecarga de los cuidadores de pacientes diabéticos en Cúcuta. Rev Cuid. 2013;4(1):459–66.

O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: a synthesis of recommendations. Acad Med. 2014;89(9):1245-51. doi: 10.1097/ACM.0000000000000388.

Taipe N. Los mitos. Consensos, aproximaciones y distanciamientos teóricos. Gaz Antropol. 2000;20(16):1–21.

Diez Patricio A. Más sobre la interpretación de ideas y creencias. Rev Asoc Esp Neuropsiq. 2017;37(131):127–43.

Braun V, Clarke V. Uso del análisis temático en psicología. Investigación Cualitativa en Psicología. 2006 3(2): 77-101.

Salazar Fonseca E, Ponce Rosas E, Jiménez Galván I, Azucena Cervantes NA, Jiménez Hernández J, et al. Mitos y creencias sobre la diabetes en pacientes de una unidad médica de atención primaria en la Ciudad de México. Archivos en medicina familiar. 2018;20(1):15-21.

León-Jiménez F, Barreto-Pérez D, Altamirano-Cardozo L, Loayza-Enríquez B, Farfán-García J. Health status evaluation of type 2 diabetes patients from two hospitals of northern Peru. Rev Cuerpo Med HNAAA. 2021;14(3):330-336. doi: 10.35434/rcmhnaaa.2021.143.1254.

Miranda Mesías R. Creencias en salud de las personas con diabetes mellitus tipo 2 Hospital I Naylamp de ESSALUD Chiclayo 2018 [tesis doctoral]. Chiclayo: Universidad San Martín de Porres; 2020. Disponible en: https://repositorio.usmp.edu.pe/bitstream/handle/20.500.12727/6587/miranda_mrr.pdf;jsessionid=A45154C4DD313016276B635ACE0C25C6?sequence=1.

Tan NC, Tan AM, Yeo JP, Rethink Study Group. RETHINK: An observational cross sectional study on the uptake of insulin therapy among type 2 diabetes patients with secondary drug failure treated in primary care. Asia Pac Fam Med. 2003;2(3):157-165. doi: 10.1046/j.1444-1683.2003.00074.x.

Jenkins N, Hallowell N, Farmer AJ, Holman RR, Lawton J. Initiating insulin as part of the Treating To Target in Type 2 Diabetes (4-T) trial: an interview study of patients’ and health professionals’ experiences. Diabetes Care. 2010;33(10):2178-80. doi: 10.2337/dc10-0494.

Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological Insulin Resistance in Patients With Type 2 Diabetes The scope of the problem. Diabetes Care. 2005;28(10):2543–5. doi: 10.2337/diacare.28.10.2543.

Nakar S, Yitzhaki G, Rosenberg R, Vinker S. Transition to insulin in Type 2 diabetes: family physicians’ misconception of patients’ fears contributes to existing barriers. J Diabetes Complications. 2007;21(4):220-6. doi: 10.1016/j.jdiacomp.2006.02.004.

Nadasen DM, Naidoo M. Patients with type 2 diabetes and difficulties associated with initiation of insulin therapy in a public

health clinic in Durban. S Afr Fam Pract. 2012;54(5):436–4. doi: 10.1080/20786204.2012.10874267.

Phillips A. Starting patients on insulin therapy: diabetes nurse specialist views. Nurs Stand 2007;21(30):35–4. doi: 10.7748/ns2007.04.21.30.35.c4540.

LaManna J, Litchman ML, Dickinson JK, Todd A, Julius MM, Whitehouse CR, et al. Diabetes Education Impact on Hypoglycemia Outcomes: A Systematic Review of Evidence and Gaps in the Literature. Diabetes Educ. 2019;45(4):349-369. doi: 10.1177/0145721719855931.

Ramírez LPA, Barrón AG, Valero KS. Concepciones Culturales Sobre Insulinoterapia De Pacientes Diabéticos Tipo 2. Rev Salud Publica y Nutr. 2012;13(1).

Liu Q, Tie L. Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Diabetes. Adv Exp Med Biol. 2019;1182:201-215. doi: 10.1007/978-981-32-9421-9_8.

Hatami E, Ghalishourani SS, Najafgholizadeh A, Pourmasoumi M, Hadi A, Clark CCT, et al. The effect of spirulina on type 2 diabetes: a systematic review and meta-analysis. J Diabetes Metab Disord. 2021;20(1):883-892.

doi: 10.1007/s40200-021-00760-z.

Dos Santos KC, Bueno BG, Pereira LF, Francisqueti FV, Braz MG, Bincoleto LF, et al. Yacon(Smallanthussonchifolius) LeafExtractAttenuatesHyperglycemiaandSkeletal MuscleOxidativeStressandInflammationinDiabeticRats. EvidBasedComplement

Alternat Med. 2017;2017:6418048. doi: 10.1155/2017/6418048.

Semlitsch T, Engler J, Siebenhofer A, Jeitler K, Berghold A, Horvath K. (Ultra-)long-acting insulin analogues versus NPH insulin (human

isophane insulin) for adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2020;11(11):CD005613. doi: 10.1002/14651858.

Ding H, Fatehi F, Russell AW, Karunanithi M, Menon A, Bird D, et al.

User Experience of an Innovative Mobile Health Program to Assist in Insulin Dose Adjustment: Outcomes of a Proof-Of-Concept Trial.

Telemed J E Health. 2018;24(7):536-543. doi: 10.1089/tmj.2017.0190.

Miranda A, Garcia DO, Sánchez C, Warren C. Health and Type 2 Diabetes Perspectives of At-Risk, Mexican-Origin Males (HD-MxOM):

a Qualitative Study. J Racial Ethn Health Disparities. 2021;8(5):1101-1111. doi: 10.1007/s40615-020-00866-9.

Organización mundial de la Salud. Nota de prensa 1 de junio 2020. La COVID 19 afecta significativamente a los servicios de salud relacionados con las enfermedades no trasmisibles [Internet]. OMS; 2020 [citado el 10 de febrero de 2022]. Disponible en: https://www.who.int/es/news/item/01-06-2020-covid-19-significantly-impacts-health-services-for-noncommunicable-diseases.